Virtus LifeSci Biotech Products ETF
11 hedge funds and large institutions have $3.58M invested in Virtus LifeSci Biotech Products ETF in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $4.47M → $3.58M (-$899K)
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$328K | |
| 2 | +$89.4K | |
| 3 | +$42.7K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$13K |
| 5 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$10K |
Top Sellers
| 1 | -$794K | |
| 2 | -$368K | |
| 3 | -$5K | |
| 4 |
Morgan Stanley
New York
|
-$4.1K |